SOX2 and urinary bladder cancer: Zhu et al. demonstrated that Sox2-expressing bladder cancer cells express high levels of CSC markers keratin14 (KRT14) and CD44v6, and that ablation of Sox2-expressing cells leads to tumor regression16.